Symbicort vs Xopenex
What to choose Symbicort or Xopenex
Symbicort is inhaler of type Control while Xopenex is of Rescue type. Symbicort and Xopenex are both brand inhalers. Symbicort is manufactured by pharmaceutical company AstraZeneca, while Xopenex is manufactured by Sunovion. The main substances of Symbicort are Budesonide and Formoterol. The available dosages for Symbicort are 100/6, 160/4.5, 200/6, 400/6. The main substance of Xopenex is Levalbuterol. The available dosage for Xopenex is 45 mcg.
The average price for Symbicort is approximately $359 per inhaler while actual price for Xopenex is around $256 per inhaler, said Rex Mitchell, a Research Associate at the Southern Connecticut State University and an Advanced Medical Support Assistant at a clinic that uses Symbicort and Xopenex.
Symbicort and Xopenex Comparison
| Symbicort | Xopenex | |
|---|---|---|
| Type: | Control | Rescue |
| Manufacturer: | AstraZeneca | Sunovion |
| Substance: | Budesonide + Formoterol | Levalbuterol |
| Dosage: | 100/6, 160/4.5, 200/6, 400/6 | 45 mcg |
| Avg Price: | $359 | $256 |